This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Keio University, Tokyo Institute of Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 360 
1 out of 591 
Years Active: 2022
Title: The Innovations of Tsukasa Nishimori
Introduction
Tsukasa Nishimori is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the development of antitumor agents. His innovative work has garnered attention for its potential impact on cancer treatment.
Latest Patents
Nishimori holds a patent for an antitumor agent that includes water-soluble sulfasalazine as an active ingredient. This invention aims to provide an effective treatment option for cancer patients. The patent describes a PEG-modified sulfasalazine, characterized by a specific formula where the average value of n is 4 or larger and 1136 or smaller.
Career Highlights
Throughout his career, Tsukasa Nishimori has been associated with prestigious institutions such as Keio University and the Tokyo Institute of Technology. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Nishimori has worked alongside notable colleagues, including Hideyuki Saya and Osamu Nagano. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Tsukasa Nishimori's contributions to the field of antitumor agents highlight his innovative spirit and dedication to improving cancer treatment. His work continues to inspire future research in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile